GGLP1 Base

Ozempic vs Wegovy

Ozempic and Wegovy share the same active molecule — semaglutide — but they are approved for different indications and used at different doses. Here is how they actually differ.

FieldOzempicWegovy
Active ingredientSemaglutideSemaglutide
FDA indicationType 2 diabetesChronic weight management
Maximum maintenance dose1.0 mg (or 2.0 mg)2.4 mg
Available doses0.25, 0.5, 1.0, 2.0 mg0.25, 0.5, 1.0, 1.7, 2.4 mg
Titration steps3-4 steps over 8-16 weeks5 steps over 16 weeks
List price (US)~$935/month~$1,350/month
Average weight loss in trials~6% at 1.0 mg over ~1 year~15% over ~17 months

Same molecule, different titration

Semaglutide is the active ingredient in both Ozempic and Wegovy. The difference is dose: Ozempic tops out at 2.0 mg weekly (with 1.0 mg as the common maintenance dose), while Wegovy is titrated to 2.4 mg as a maintenance dose specifically for weight loss. Wegovy's slower five-step titration is designed to improve tolerability at the higher dose.

Indication and insurance

Ozempic is approved by the FDA for adults with type 2 diabetes, and insurance coverage for that indication is widespread. Wegovy is approved for chronic weight management in adults with obesity or weight-related conditions, and coverage is much more variable — many commercial plans cover it conditionally, Medicare offers limited coverage, and Medicaid coverage depends on the state. Using Ozempic off-label for weight loss is common but generally not covered by insurance.

Side effects

Both drugs share the same family of side effects — nausea, diarrhea, constipation, vomiting, abdominal pain — because they are the same molecule. Wegovy's higher maintenance dose tends to produce more pronounced side effects in some patients, which is why the titration is slower.

Choosing between them

If you have type 2 diabetes, Ozempic is the appropriate label. If your primary goal is chronic weight management, Wegovy is the labeled choice. Many providers will not prescribe Ozempic off-label for weight loss, in part because it leaves Wegovy patients with supply during periods of shortage. Your clinical situation, insurance, and your prescriber's preferences will all factor in.